Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CIMESTRA: Cyclosporine + Methotrexate in Early RA
NCT00209859Phase 4Completed
- Sponsor
- Copenhagen University Hospital - Hvidovre
- Start
- Oct 1998
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of cyclosporine in rheumatoid arthritis (RA) (2 arms), sponsored by Copenhagen University Hospital - Hvidovre. Primary endpoint: American College of Rheumatology 20% Response at 2 years. Started Oct 1998; status: completed.
02
Drugs
cyclosporine
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT00209859.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00209859.